Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Rad Laboratories

256.68
+2.210.87%
Post-market: 256.680.00000.00%19:09 EDT
Volume:1.44M
Turnover:368.07M
Market Cap:7.19B
PE:-3.93
High:256.74
Open:252.58
Low:250.70
Close:254.47
Loading ...

Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference

GlobeNewswire
·
03 Feb

Reviva to Participate in the 2025 BIO CEO & Investor Conference

GlobeNewswire
·
30 Jan

Strengthening America's Biosecurity: GeoVax Advances Domestic Vaccine Capability

NewMediaWire
·
29 Jan

Bio-Rad Laboratories, Inc. (BIO): Is This Healthcare Stock A Good Buy?

Insider Monkey
·
29 Jan

Press Release: Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025

Dow Jones
·
28 Jan

Strong week for Bio-Rad Laboratories (NYSE:BIO) shareholders doesn't alleviate pain of three-year loss

Simply Wall St.
·
28 Jan

3 Altcoins That Reached All-Time Low Today — January 27

BE[IN]CRYPTO
·
28 Jan

BIO-UV Group Launches Capital Increase to Fund Growth Initiatives

TIPRANKS
·
24 Jan

SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy

GlobeNewswire
·
23 Jan

Bell Potter Remains a Buy on Biome Australia Ltd (BIO)

TIPRANKS
·
21 Jan

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?

Zacks
·
17 Jan

Why Bio-Rad Stock is an Apt Pick for Your Portfolio Right Now

Zacks
·
17 Jan

Bio-Rad Laboratories Price Target Maintained With a $481.00/Share by RBC Capital

Dow Jones
·
15 Jan

Bio-Rad Laboratories Led $105 Million Series C Funding Round for Geneoscopy

MT Newswires Live
·
08 Jan

BRIEF-Geneoscopy Closes $105M In Series C Funding Round

Reuters
·
08 Jan

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

THOMSON REUTERS
·
08 Jan